Abstract Flat epithelial atypia (FEA) may represent the earliest precursor of low-grade breast cancer and often coexists with more advanced atypical proliferative breast lesions such as atypical ductal hyperplasia (ADH) and lobular intraepithelial neoplasia (LIN). The present study aims to investigate the association between morphological parameters of FEA and presence of malignancy at surgical excision (SE) and the clinical significance of the association of with ADH and/or LIN. This study included 589 cases of stereotactic 11-gauge vacuum-assisted needle core biopsy (VANCB), reporting a diagnosis of FEA, ADH or LIN with subsequent SE from 14 pathology departments in Italy. Available slides were reviewed, with 114 (19.4 %) showing a malignant outcome at SE. Among the 190 cases of pure FEA, no statistically significant association emerged between clinical-pathological parameters of FEA and risk of malignancy. Logistic regression analyses showed an increased risk of malignancy according to the extension of ADH among the 275 cases of FEA associated with ADH (p00.004) and among the 34 cases of FEA associated with ADH and LIN (p00.02). In the whole series, a statistically significant increased malignancy risk emerged according to mammographic R1-R3/R4-R5 categories (OR01.56; p0 0.04), extension (OR01.24; p00.04) and grade (OR01.94; p00.004) of cytological atypia of FEA. The presence of ADH was associated with an increased malignancy risk (OR02.85; p<0.0001). Our data confirm the frequent association of FEA with ADH and/or LIN. A diagnosis of pure FEA on VANCB carries a 9.5 % risk of concurrent malignancy and thus warrants follow-up excision because none of the clinical-pathological parameters predicts which cases will present carcinoma on SE.
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Introduction
Widespread implementation of mammography screening programmes and the introduction of digital mammography in the pre-clinical diagnosis of breast lesions have led to an increasing number of core biopsies (CB) performed for nonpalpable nodules and microcalcifications. In the diagnostic assessment of microcalcifications, stereotactic 11-gauge vacuum-assisted needle core biopsy (VANCB) has a lower underestimation rate for malignancy than stereotactic 14-gauge needle core biopsy (NCB) [1] . On CB performed for indeterminate or suspicious microcalcifications, a lesion designated as flat epithelial atypia (FEA) is frequently diagnosed.
FEA, for which the term ductal intraepithelial neoplasia grade 1a (DIN1a) is also used, was introduced by the World Health Organization (WHO) Working Group on the Pathology and Genetics of Tumors of the Breast [2] with the aim of unifying columnar cell lesions with low-grade of cytological atypia, characteristically without complex architectural atypia in the form of arcades, bars, Roman bridges, tufts or micropapillae that are essential in distinguishing this lesion from atypical ductal hyperplasia (ADH or DIN1b).
For FEA, a variety of terms has been proposed [3] . Azzopardi [4] introduced the term clinging carcinoma in situ for this lesion, which can be mistaken for either normal breast tissue or fibrocystic breast change.
Although the biological and clinical significance of FEA is still far from completely understood, emerging histological and molecular evidence suggests that FEA may represent the earliest morphologically identifiable non-obligatory precursor of low-grade breast cancer [5, 6] . In fact, FEA often coexists with more advanced atypical proliferative breast lesions such as ADH and atypical lobular hyperplasia (LIN1/ALH) or low-grade ductal carcinoma in situ (DCIS, particularly micropapillary and cribriform type), lobular carcinoma in situ (LIN2/LCIS), tubular carcinoma and invasive lobular carcinoma (ILC) [7] [8] [9] [10] [11] [12] . Otherwise, the possibility that columnar cell lesions in general and FEA in particular significantly elevate breast cancer risk is at the moment not well supported [13, 14] .
From a clinical point of view, a diagnosis of FEA on CB, pure or in association with more advanced atypical proliferative breast lesions, impacts on the management of these patients. Based on the underestimated malignancy rates of patients with a CB diagnosis of FEA, the prevailing recommendation remains surgical excision (SE) [15] .
The aims of our study were to evaluate: (1) if morphological parameters of pure FEA can predict malignancy (DCIS or invasive carcinoma) in subsequently performed SE, (2) the frequency of association of FEA with more advanced atypical proliferative breast lesions such as ADH and/or lobular intraepithelial neoplasia (LIN) and (3) the clinical significance of ADH and or LIN associated with FEA in terms of finding DCIS or invasive carcinoma in subsequently performed SE.
Materials and methods
The study population of a large Italian multi-institutional series of stereotactic VANCB, performed using an 11-gauge stereotactic vacuum-assisted device (Mammotome®, Ethicon Endo-Surgery, Breast Care, Norderstedt, Germany), has been previously reported [1] . Of 22 institutions participating in that study, 14 agreed to proceed with a histological review of all VANCB and SE specimens: eight from Northern Italy, three from Central Italy and three from Southern Italy. Institutional review board approvals were obtained for the study from each participating centre.
Pathology departments participating in the study were asked to retrieve from their archival files all available slides of consecutive B3 cases from VANCB specimens related to the study period [1] and reported in the original histological diagnosis as FEA, atypical epithelial proliferation of ductal type/ADH and LIN. In all participating pathology departments, once a diagnosis of FEA was considered, at least three additional levels of sectioning of VANCB, generally taken approximately at 25 μm apart, were routinely performed in view of the possibility of coexisting more advanced atypical proliferative breast lesions such as ADH and LIN1/ALH. Only VANCB cases with subsequent SE were included in this study.
Radiology departments participating in the study were asked to provide for each case the age of patient, mammographic pattern (microcalcifications versus other patterns), mammographic category according to BI-RADS (Breast Imaging Reporting and Data System) five-point (R1-R5) classification system [16] , number of tissue cores obtained (12, 13-20, 21+ ) and presence of residual microcalcifications on post-stereotactic VANCB radiograms.
An electronic spreadsheet to record clinical, radiological and histological data was used. Each pathologist participating in the study reviewed all haematoxylin & eosin (H&E) and immunohistochemically stained slides, when routinely obtained, of his/her own VANCB cases. The following morphological parameters were evaluated: (a) presence of determinant microcalcifications within the index lesion, (b) presence of unrelated microcalcifications, (c) patterns of FEA (cystically dilated glands, blunt duct adenosis (BDA) resembling pattern on low power, presence of apocrine features as reported by Kunju et al. [11] ), (d) grade of cytological atypia of FEA: mild atypia (characterized by relatively round or ovoid rather than elongated nuclei with a slight increase in the nuclear/cytoplasmic ratio, finely dispersed chromatin or slight margination of chromatin, variably prominent nucleoli and loss of polarity) or moderate atypia (characterized by enlarged, more oval nuclei with cytologically atypical features including mild to moderate pleomorphism, prominent nucleoli, some clumping of chromatin and increased nuclear/cytoplasmic ratio) as described by Pinder et al. [17, 18] , (e) patterns of ADH (cribriform, micropapillary, solid or with presence of apocrine features) according to Kunju et al. [11] , (f) patterns of LIN (LIN1/ALH or LIN2/ LCIS), (g) presence of chronic inflammation and (h) presence of stromal changes including fibrosis and myxoid change.
FEA was diagnosed according to strict morphological criteria [2, 19] : variably distended acini lined by one to several layers of monotonous, mildly or moderately atypical, cuboidal to columnar cells growing in an exclusively flat pattern in the complete absence of architecturally atypical intraluminal proliferations. The presence of a single atypical intraluminal structure as arcade, bar, Roman bridge, tuft or micropapillary formation was considered enough for a diagnosis of FEA associated with concomitant ADH.
ADH was diagnosed using combined histological and cytological criteria as established by Page and Rogers [20] : a proliferative lesion that fulfils some but not all qualitative criteria for a diagnosis of intraductal carcinoma, i.e. evenly spaced cells with hyperchromatic nuclei coexisting with patterns of usual ductal hyperplasia or columnar cell changes, producing a partial involvement of glandular structure by neoplastic cells. In CB histology, technical issues hamper the application of quantitative criteria in diagnosing ADH [21] .
In the histological revision, LIN was subdivided into atypical lobular hyperplasia (LIN1/ALH) and lobular carcinoma in situ (LIN2/LCIS). LIN1/ALH was defined by filling and distension of fewer than half of the terminal duct units of a lobule with uniform small dyscohesive cells, evenly spaced, with round nuclei and minimal pleomorphism. LIN2/LCIS was diagnosed when more than half of the acini in the terminal duct units were completely filled or distended [22] . The presence of a single lobule with morphological characteristics of LIN1 or LIN2 was considered sufficient for a diagnosis of FEA associated with LIN. The extent of involvement was determined by evaluating the number of large ducts and/or terminal duct lobular units affected by FEA, ADH and LIN as described by Ely et al. [23] and Wagoner et al. [24] . Cases were divided according the number of foci affected in: (a) cases confined to one focus, (b) cases limited to two foci, (c) cases limited to three foci and (d) cases with four or more foci. The reviewed VANCB final diagnoses were coded into seven categories as follows: pure FEA, pure ADH, pure LIN, FEA + ADH, FEA + LIN, ADH + LIN, FEA + ADH + LIN. In each pathology department participating in the study, histology reports and slides of subsequent SE were collected. Each local pathologist reviewed all H&E slides of subsequent SE of his/her VANCB cases included in the study and reported them as: (a) malignant lesions specifying histotype, histological grade, size and lymph node status for invasive carcinoma, nuclear grade and size for DCIS and size for pleomorphic lobular carcinoma in situ, (b) atypical lesions specifying if FEA, ADH, ALH, LCIS were pure or in association and (c) benign lesions. Pathologists were asked to select for each VANCB case one or more representative H&E-stained slides and, where appropriate, IHC-stained slides of the lesion to be reviewed jointly by the panel of 14 pathologists participating in the study. The selected slides of all VANCB cases included in the study were reviewed during a meeting organized at the Division of Pathological Anatomy of the University of Florence in September 2010 to obtain concordance on the diagnosis on each VANCB. Slides were reviewed using the Leica 
Statistical analysis
The distribution of the histological diagnoses reported for the 859 VANCB specimens was calculated. The distribution of the histological diagnoses after SE (benign, atypical or malignant lesion) was also established as well as the percentage of cases with malignancy (according to each specific diagnosis at VANCB).
For all cases with a diagnosis of FEA (pure or associated with other lesions), the distribution according to the following variables was calculated: mammographic category (R2-R3, R4-R5), mammographic pattern (microcalcifications, other), determinant microcalcifications (yes, no), number of cores (12, 13-20, >20), chronic inflammation (yes/no), stromal changes (yes/no), pattern of FEA (blunt duct adenosis resembling pattern, cystically dilated glands, apocrine features), extension of FEA (one focus, two foci, three foci, four foci or more), grade of cytological atypia of FEA (mild, moderate), pattern of ADH (cribriform, micropapillary, solid or with presence of apocrine features), extension of ADH (one focus, two foci, three foci, four foci or more), pattern of LIN (ALH/LIN1 or LCIS/LIN2), extension of LIN (one focus, two foci, three foci, four foci or more). P values from chi-square test or Fisher exact test were also calculated. Mean age at VANCB diagnosis according to malignant outcome (p values from between-mean comparison t tests) was also calculated. Logistic regression models were used to compute odd ratios (ORs) and 95 % confidence intervals (95 % CIs) for each FEA-related variable as estimate of malignant breast cancer risk. Logistic regression analyses were performed separately for a diagnosis on VANCB of pure FEA, of FEA + ADH, of FEA + LIN and of FEA + ADH + LIN. Logistic models were adjusted for age at VANCB diagnosis of the cases, grade of cytological atypia of FEA, pattern and extension of ADH or LIN or both, respectively.
Logistic regression analyses were also performed for all cases including a VANCB diagnosis of FEA (pure FEA or FEA + ADH or FEA + LIN or FEA + ADH + LIN). Logistic models were adjusted for age at VANCB diagnosis, grade of cytological atypia of FEA and copresence of ADH or LIN.
Results
A total of 859 histologically reviewed VANCB cases with a subsequent SE were available including pure FEA (Figs. 1 and 2) (N0190, 22.1 %), pure LIN (N0149, 17.3 %), pure ADH (N0108, 12.6 %), FEA associated with ADH ( Fig. 3) (N0275, 32.0 %), FEA associated with LIN (Fig. 4) Fig. 5 , DCIS was the most frequent malignancy at SE among all the types of VANCB diagnosis. The median age of patients with pure FEA was 50.7 years, 51.9 years for FEA + ADH, 49.9 years for FEA + LIN and 52.6 years for FEA + ADH + LIN (data not shown).
In Tables 2, 3 , 4 and 5, the distribution of cases with a VANCB diagnosis of pure FEA, FEA + ADH, FEA + LIN and FEA + ADH + LIN, respectively, according to malignancy upon SE, and several FEA and/or ADH and/or LINrelated variables is reported together with the results of multivariate analyses. The risk of malignancy in women with moderate cytological atypia showed a trend towards being increased ( Table 2 ) compared with that of women with mild cytological atypia (χ 2 test, p00.06). The suggestion was confirmed by logistic regression analysis (OR 2.41; p00.08). The suggestion that complete removal of microcalcifications was less frequently associated with malignancy (two cases out of 48 or 4.2 % showing malignancy at surgery) than incomplete removal was not statistically significant (16 out of 142 or 11.3 %).
In Table 3 (FEA + ADH), an increased risk of malignancy according to the extension of ADH emerged in a model adjusted for age, grade of cytological atypia of FEA and pattern of ADH (OR 1.45, p value 0.004). In Table 4 (FEA + LIN), an increased risk of malignancy in patients with a moderate grade of cytological atypia of FEA compared to patients with a mild grade of cytological atypia emerged (OR 5.22, p value 0.03). In Table 5 (FEA + ADH + LIN), an increased risk of malignancy according to the extension of ADH emerged (OR 6.71, p value 0.02).
According to Table 6 , women in the mammographic category R4-R5 had an increased risk of malignancy compared with those in R2-R3 category (OR 1.56, 95 % CI .0001). The mean age of women with malignancy at SE was significantly higher than that of women with a non-malignant outcome (53.4 vs 50.7 years, p00.001).
Discussion
Our study, although limited by its retrospective design, to the best of our knowledge, represents the largest series published to date of FEA, pure or in association with more advanced lesions such as ADH and or LIN, diagnosed on stereotactic 11-gauge VANCB with subsequent follow-up surgical excision. It may contribute to the assessment of the clinical and biological significance of pure FEA and to the management of patients with VANCB diagnosis of pure FEA. All VANCB cases were histologically reviewed and diagnoses were agreed by the panel of 14 pathologists participating in the study using non-ambiguous terminology [25, 26] .
Pure FEA On CB performed for indeterminate or suspicious microcalcifications, a lesion designated as flat epithelial atypia is increasingly recognized and diagnosed [1] . The preoperative histological diagnosis of FEA poses a management dilemma for the clinician. Although there is no definitive agreement at present on the clinical management of FEA (underestimation rates for CB diagnosis of pure FEA reported in the literature vary from 0 to 67 % [13] ), the currently prevailing recommendation is that it warrants follow-up surgical excision [1, 27] . A few studies in the published literature support the follow-up observation for the management of pure FEA [26, 28, 29] . A recent review [15] reported a pooled underestimation rate of 12 % for FEA in VANCB (in good agreement with our 12.7 % [1]) compared to 17 % in studies restricted to NCB (difference not statistically significant). Consequently, the authors concluded that surgical excision should be considered. On the other hand, the data reported mostly concern small series (range 1-60 cases), partly published only in abstract form, mostly lacking standardized terminology (including pure FEA and FEA with ADH and or LIN). No single or a combination of clinical, radiological or pathological criteria clearly identified a subset of pure FEA cases at low risk of malignancy. Thus, our results and other recent data [27] justify the conclusion that the presence of pure FEA on VANCB warrants follow-up excision. The identification of FEA also poses a diagnostic challenge to the pathologist, particularly in CB, because FEA with mild cytological atypia may be subtle and care should be taken not to overlook the lesion or to over-diagnose it and reporting as atypical any columnar cell lesion [17, 18] .
Our results confirm previous reports [11, [25] [26] [27] that almost all patients (185/190, 97.4 %) with pure FEA are [11, 12, 26, 27, 30] . The association of FEA with ADH has an important impact on clinical management as for ADH on CB the need for surgical excision is unanimously recognized [31] . The positive predictive value for malignancy of FEA associated with ADH on CB significantly increases when compared to that of pure FEA [11, 26] . We found that 27.3 % (75/ 275) of FEA associated with ADH showed a malignancy at follow-up SE. Our study confirms the strong association between FEA and ADH on CB. Our data, together with data from other observational [26] and molecular studies [5] [6] support the hypothesis that FEA represents the earliest precursor of low-grade ductal carcinoma, both in situ and invasive [19] .
FEA associated with LIN Some investigators have reported the coexistence of FEA and LIN in the same surgical specimen, particularly in cases of tubular carcinoma [7, 32, 33] . Recently, Abdel-Fatah et al. [8] found that columnar cell lesions, predominantly FEA, and LIN coexist in 60 % of cases of ILC, suggesting that the loss of E-cadherin expression may switch on the development of lobular differentiation, and proposed an evolutionary pathway of ILC through columnar cell lesions on the basis of histological evidence and common genetic changes. We found FEA associated with LIN in 15.3 % (90/589) of cases, in agreement with data reported by Levoue et al. [27] , which results in a malignancy underestimation rate of 14.4 %.
FEA associated with ADH and LIN In 5.8 % (34/589) of our cases, we found FEA associated both with ADH and LIN, resulting in an underestimation rate of malignancy of 23.5 %, which is closer to the underestimation rate of FEA + ADH (27.3 %) than that of FEA + LIN (14.4 %). This indicates that ADH determines the natural history of the lesion. In FEA associated with both ADH and LIN, the extension of ADH seems to be strongly associated with the risk of malignancy.
Taken together, in our series 19.4 % (114/589) of cases with a mention of FEA (pure FEA and/or FEA associated to ADH and/or LIN) showed a malignancy at subsequent SE.
The risk of malignancy increased along with the mammographic category, the extension of FEA and the grade of cytological atypia of FEA, while the association with ADH was a strong predictor of malignancy. The median age of patients with pure FEA was slightly younger than that of patients with FEA + ADH and FEA + ADH + LIN (50.7, 51.9 and 52.6 years, respectively) but slightly older compared to those with FEA + LIN (49.9 years, as reported earlier) [11, 26] .
Conclusion
None of the studied parameters of pure FEA can predict the risk of malignancy in a subsequent SE. A trend was found only for the grade of cytological atypia (mild versus moderate) and incomplete removal of microcalcifications.
In FEA associated with ADH or ADH and LIN, the risk of malignancy increases along with increasing extension of ADH. In FEA associated with LIN, the risk of malignancy is higher in case of moderate cytological atypia of FEA. The risk of malignancy in FEA increased according to mammographic category, extension of FEA and grade of cytological atypia of FEA.
A diagnosis of pure FEA on VANCB warrants SE because, on the basis of clinical-pathological parameters, it is impossible to predict which cases are associated with carcinoma. The absence of residual microcalcifications on post-VANCB mammography does not exclude the presence of an associated malignancy at SE: we found malignancy in 4 % (2/48), 10 % (5/50) and 16.7 % (2/12) of cases with complete removal of microcalcifications by VANCB in pure FEA, FEA + ADH and FEA + ADH + LIN, respectively.
We therefore confirm the frequent association of FEA with more advanced atypical proliferative breast lesions such as ADH and/or LIN [17] [18] [19] 34] and support the recommendation proposed by several authors [25, 30] that deeper levels of CB with pure FEA should be examined in order to detect or exclude the co-existence of more advanced breast lesions. The findings concerning the frequent association of FEA with more advanced atypical proliferative breast lesions support the hypothesis that FEA, together with ADH and LIN, belongs to the family of precursor lesions of low grade in situ and invasive breast cancer [5, 8] as the earliest precursor recognized to date.
